GE HistoryCareは,日本のラジオ薬会社ニホン・メディ=ピシックスの完全所有権を購入. GE HealthCare buys full ownership of Japanese radiopharmaceutical firm Nihon Medi-Physics.

GE HealthCareは,Sumitomo Chemicalから残りの50%の株式を購入することで,日本の有力な放射性医薬品会社であるNihon Medi-Physics (NMP) の完全な所有権を取得しています. GE HealthCare is acquiring full ownership of Nihon Medi-Physics (NMP), a leading Japanese radiopharmaceutical company, by purchasing the remaining 50% stake from Sumitomo Chemical. 規制当局の承認を受ければ2025年初めに完了すると予想される買収は,分子画像技術におけるGE HealthCareの地位を高め,日本での存在を拡大します. The acquisition, expected to close in early 2025, subject to regulatory approvals, will enhance GE HealthCare's position in molecular imaging and expand its presence in Japan. NMPの医薬品はSPECTやPET画像で病気の診断に用いられ,この取引でGEヘルスケアの医薬品診断部門を強化する. NMP's radiopharmaceuticals are used in SPECT and PET imaging to diagnose diseases, and the deal will bolster GE HealthCare's Pharmaceutical Diagnostics segment.